These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 20433322

  • 21. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Dmitrzak-Weglarz M, Czerski PM, Hauser J.
    World J Biol Psychiatry; 2006; 7(3):158-61. PubMed ID: 16861141
    [Abstract] [Full Text] [Related]

  • 22. Lithium prophylaxis during pregnancy and the postpartum period in women with lithium-responsive bipolar I disorder.
    Rosso G, Albert U, Di Salvo G, Scatà M, Todros T, Maina G.
    Arch Womens Ment Health; 2016 Apr; 19(2):429-32. PubMed ID: 26790685
    [Abstract] [Full Text] [Related]

  • 23. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E, Iancu I, Horesh N, Strous RD, Kotler M.
    Depress Anxiety; 2007 Apr; 24(8):571-6. PubMed ID: 17133442
    [Abstract] [Full Text] [Related]

  • 24. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A, Skibinska M, Suwalska A, Hauser J, Rybakowski JK.
    Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
    [Abstract] [Full Text] [Related]

  • 25. Rapid cycling bipolar disorder--diagnostic concepts.
    Bauer M, Beaulieu S, Dunner DL, Lafer B, Kupka R.
    Bipolar Disord; 2008 Feb; 10(1 Pt 2):153-62. PubMed ID: 18199234
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bipolar II disorder: arguments for and against a distinct diagnostic entity.
    Vieta E, Suppes T.
    Bipolar Disord; 2008 Feb; 10(1 Pt 2):163-78. PubMed ID: 18199235
    [Abstract] [Full Text] [Related]

  • 29. Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes.
    Rybakowski JK, Suwalska A, Skibinska M, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J.
    Am J Med Genet B Neuropsychiatr Genet; 2007 Sep 05; 144B(6):820-3. PubMed ID: 17373693
    [Abstract] [Full Text] [Related]

  • 30. Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
    Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Szczepankiewicz A, Hauser J.
    Pharmacogenomics; 2008 Nov 05; 9(11):1595-603. PubMed ID: 19018715
    [Abstract] [Full Text] [Related]

  • 31. Genetics of Lithium Response in Bipolar Disorder.
    Papiol S, Schulze TG, Alda M.
    Pharmacopsychiatry; 2018 Sep 05; 51(5):206-211. PubMed ID: 29579760
    [Abstract] [Full Text] [Related]

  • 32. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.
    Mitjans M, Arias B, Jiménez E, Goikolea JM, Sáiz PA, García-Portilla MP, Burón P, Bobes J, Vieta E, Benabarre A.
    J Clin Psychopharmacol; 2015 Oct 05; 35(5):600-4. PubMed ID: 26267417
    [Abstract] [Full Text] [Related]

  • 33. Functional genetic variation in the Rev-Erbα pathway and lithium response in the treatment of bipolar disorder.
    McCarthy MJ, Nievergelt CM, Shekhtman T, Kripke DF, Welsh DK, Kelsoe JR.
    Genes Brain Behav; 2011 Nov 05; 10(8):852-61. PubMed ID: 21781277
    [Abstract] [Full Text] [Related]

  • 34. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.
    Alda M.
    Mol Psychiatry; 2015 Jun 05; 20(6):661-70. PubMed ID: 25687772
    [Abstract] [Full Text] [Related]

  • 35. Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders.
    Serretti A, Lorenzi C, Lilli R, Smeraldi E.
    J Psychiatr Res; 2000 Jun 05; 34(2):89-98. PubMed ID: 10758249
    [Abstract] [Full Text] [Related]

  • 36. Is lithium still worth using? An update of selected recent research.
    Baldessarini RJ, Tondo L, Hennen J, Viguera AC.
    Harv Rev Psychiatry; 2002 Jun 05; 10(2):59-75. PubMed ID: 11897747
    [Abstract] [Full Text] [Related]

  • 37. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
    Lin YF, Huang MC, Liu HC.
    J Affect Disord; 2013 May 05; 147(1-3):401-6. PubMed ID: 23021822
    [Abstract] [Full Text] [Related]

  • 38. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.
    Schulze TG, Alda M, Adli M, Akula N, Ardau R, Bui ET, Chillotti C, Cichon S, Czerski P, Del Zompo M, Detera-Wadleigh SD, Grof P, Gruber O, Hashimoto R, Hauser J, Hoban R, Iwata N, Kassem L, Kato T, Kittel-Schneider S, Kliwicki S, Kelsoe JR, Kusumi I, Laje G, Leckband SG, Manchia M, Macqueen G, Masui T, Ozaki N, Perlis RH, Pfennig A, Piccardi P, Richardson S, Rouleau G, Reif A, Rybakowski JK, Sasse J, Schumacher J, Severino G, Smoller JW, Squassina A, Turecki G, Young LT, Yoshikawa T, Bauer M, McMahon FJ.
    Neuropsychobiology; 2010 May 05; 62(1):72-8. PubMed ID: 20453537
    [Abstract] [Full Text] [Related]

  • 39. [Pharmacotherapy in bipolar disorders during childhood and adolescence].
    Vloet JA, Hagenah UF.
    Z Kinder Jugendpsychiatr Psychother; 2009 Jan 05; 37(1):27-49, quiz 49-50. PubMed ID: 19105162
    [Abstract] [Full Text] [Related]

  • 40. The lithium ion: a foundation for psychopharmacological specificity.
    Soares JC, Gershon S.
    Neuropsychopharmacology; 1998 Sep 05; 19(3):167-82. PubMed ID: 9653704
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.